“Chinese products are cheaper and scalable, which is so important for developing countries.”
China now runs more clinical trials than the U.S. and signs half the world’s drug licensing deals. It gave the first commercial approval anywhere for an invasive brain-computer interface. The American model prices drugs at whatever insurers will bear. Developing countries cannot pay that, so they buy Chinese.